专题:Psychedelics and Drug Studies

This cluster of papers explores the therapeutic potential of psychedelic therapy, particularly focusing on the use of substances like psilocybin and MDMA for the treatment of depression, anxiety, and substance dependence. The research delves into the neurobiology, serotonin receptors, and brain function underlying the effects of these psychedelics, as well as their ability to induce mystical experiences and promote long-lasting positive changes in psychological functioning.
最新文献
Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways Forward

article Full Text OpenAlex

Cannabis and Mental Health

article Full Text OpenAlex

Effects of Psycho Education on Intention to Use Substances among Adolescents in some Selected Schools in Enugu State, Nigeria

article Full Text OpenAlex

Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy

book-chapter Full Text OpenAlex

Classifying Psychedelic-Related Complications

book-chapter Full Text OpenAlex

Psychedelics, Harm Reduction, and Ethical Care

article Full Text OpenAlex

Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones

article Full Text OpenAlex

The first on the dark side of the moon: Revisiting the first nonblind placebo trial

article Full Text OpenAlex

The potential of event-related beta oscillations as biomarkers for neuromodulatory treatment efficacy

article Full Text OpenAlex

The science of psychedelic medicine

article Full Text OpenAlex

近5年高被引文献
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

article Full Text OpenAlex 984 FWCI177.5499

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

letter Full Text OpenAlex 605 FWCI110.0058

Novel and emerging treatments for major depression

review Full Text OpenAlex 518 FWCI84.7146

Single-Dose Psilocybin Treatment for Major Depressive Disorder

article Full Text OpenAlex 428 FWCI136.869

Increased global integration in the brain after psilocybin therapy for depression

article Full Text OpenAlex 413 FWCI75.6258

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

article Full Text OpenAlex 412 FWCI132.5654

Psychedelics promote plasticity by directly binding to BDNF receptor TrkB

article Full Text OpenAlex 399 FWCI127.5979

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

article Full Text OpenAlex 392 FWCI72.7467

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

article Full Text OpenAlex 350 FWCI111.6082

Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial

article Full Text OpenAlex 325 FWCI59.7067